Tags
- A
- ACCE
- Acro
- Across
- Administration
- Advanced
- Advancing
- Agriculture in the United States
- An
- A New Option
- Antitarget
- Approval
- Approved
- Around the World
- Asset
- Australia
- Based on
- Blood vessel
- BSC
- Buisine
- Cancer
- Capsule
- Care
- Chemotherapy
- China
- Colorectal cancer
- Combination
- Combination therapy
- Come
- Commercialization
- Commission
- Company profile
- Company profiles
- Competition
- Competitive advantage
- Competitors
- Comprehensive
- Conducting
- CRC
- Daily News
- Demonstration
- Development
- Disease
- Drug
- Edge
- Endothelium
- Endpoints
- Enhance
- Europe
- European
- European Commission
- European Union
- Factor
- FDA
- Following
- Food
- Food and Drug Administration
- Gain
- Global Oncology
- Growth
- Growth factor
- Growth factor receptor
- Health
- Health care
- Healthcare products
- Hong Kong
- Hour
- Hours
- Industry insights
- Inhibition
- Inhibitor
- In Japan!
- In Line
- Insights
- International
- Japan
- Japanese
- Kinase
- Kong
- Labour
- Large intestine
- latest
- Leader
- License
- Limit
- Limits
- Macau
- Mainland
- Mainland China
- Manufacturing
- Market
- Marketing
- Medicine
- Metástasis
- Ministry
- Ministry of Health
- Ministry of Health, Labour, and Welfare
- Most
- Need
- New
- News round-up
- Number
- Observation
- Oncology
- Oncology business unit
- Option
- Options
- Patient
- Pharmaceutical drug
- Pharmacovigilance
- Phase
- Phase III
- Placebo
- PLU
- Position
- Positions
- Primary
- Product
- Profile
- Profiles
- Progressed
- Progression-free survival
- Receptor
- Recurrence
- Regions
- Regulation
- Regulatory agency
- Research
- Round-Up
- Safety
- Save
- Secondary
- Secondary endpoints
- Selectivity
- Sign up
- Sole
- Special administrative regions of China
- Strategic business unit
- Supportive
- Survival
- Survival rate
- Sustain
- Takeda
- Target
- The Asset
- The european
- The international
- Therapeutic options
- Therapy
- The trial
- The world
- Treat
- Trial
- U.K.
- Union
- United Kingdom
- Urgently
- Vascular endothelial growth factor
- VEGF receptor
- Welfare
- Who